论文部分内容阅读
目的探讨全程化疗药物标识在降低恶性血液病化疗患者护理风险中的应用效果。方法成立静脉治疗专科护理小组,建立并应用全程化疗药物标识,对护士进行给药资质培训。应用前后比较护士化疗药物配置时间、取药正确率及患者与家属的满意度。结果化疗标识应用后,护士一次性完成化疗药物配置时间由(17.24±5.94)s下降到(8.85±2.74)s(P<0.05),取药不正确率由7.5%下降到1.0%(P<0.05),患者满意度明显提高(P<0.01)。结论建立全程化疗药物标识,可有效促进规范化、科学化和系统化管理,提高工作效率,提高护理质量和患者的满意度,降低化疗护理风险,保障患者安全。
Objective To investigate the effect of full-course chemotherapy drug labeling in reducing the nursing risk of patients with malignant hematological diseases. Methods Set up a specialist nursing team for intravenous therapy, establish and apply the whole course of chemotherapy drug identification, and train the nurses on the qualification of drug delivery. Before and after the application of nurse chemotherapy drug allocation time, taking the correct rate and patient and family satisfaction. Results After the application of chemotherapy markers, the time of one-time completion of chemotherapy for nurses dropped from (17.24 ± 5.94) s to (8.85 ± 2.74) s (P <0.05), and the incorrect sampling rate decreased from 7.5% to 1.0% (P < 0.05), patient satisfaction was significantly improved (P <0.01). Conclusion The establishment of full-course chemotherapy drug identification can effectively promote the standardization, scientific and systematic management, improve work efficiency, improve the quality of care and patient satisfaction, reduce the risk of chemotherapy and care to protect the safety of patients.